About this book


Mohamad Mohty MD, PhD

Mohamad Mohty is full Professor of Hematology and head of the Hematology and cellular therapy Department at the Saint-Antoine Hospital and Sorbonne University (Paris, France).
Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK.
Professor Mohty’s is also head of a translational research team (INSERM team N°7) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and hypomethylating agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of acute leukemia and multiple myeloma.
Professor Mohty is currently president of the European Society for Blood and Marrow Transplantation (EBMT). He serves on the board of the EBMT, and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, and EBMT.
Professor Mohty has published more than 500 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals.
He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, as member of the editorial board of Haematologica, and as a regular reviewer in different immunology, hematology, and cancer journals such as Blood, J Clin Oncol, The Lancet, and Nature Reviews.

Jean-Luc Harousseau, MD

Jean-Luc Harousseau is Professor of Hematology at the University of Nantes in France. He has been Chairman of the French National Authority for Health from 2011 to 2016 and Chair of its Economic and Public Health Evaluation Committee from 2014 to 2016. He headed the Department
of Clinical Hematology in Nantes teaching Hospital for 24 years and was Director of the Cancer Center René Gauducheau in Nantes from October 2008 to January 2011. In his previous position, he was a member of the Scientific Advisory Board of the French National Cancer Institute and
President of the Clinical Research in Oncology National Committee from October 2008 to January 2011. He was a founding member of the Groupe Ouest-Est Leucémies Aigues et Maladies du Sang and of the Intergroupe Français du Myélome, and President of this internationally renowned cooperative group from June 2009 to January 2011. Professor Harousseau is a member of the European Hematology Association, the European Group for Blood and Marrow Transplantation, the American Society of Hematology and the American Society of Clinical Oncology. He was member of the Scientific Advisory Board for the Multiple Myeloma Research Foundation and the International Myeloma Foundation. His areas of research interest concern the therapy of acute myeloid leukemia and multiple myeloma. He received the 2005 Waldenström Award and the 2009 Robert A Kyle Award for his scientific contribution in the field of multiple myeloma. Professor Harousseau has contributed to more than 500 peer-reviewed publications.

Copyright Information

This book is derived from the Handbook of Multiple Myeloma © Springer International Publishing Switzerland 2015
ISBN 978-3-319-18217-9 ISBN 978-3-319-18218-6 (eBook) DOI 10.1007/978-3-319-18218-6
Springer Cham Heidelberg New York Dordrecht London

Handbook of Multiple Myeloma – Second Edition © Springer International Publishing Switzerland 2018

This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher’s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.